Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer

• Sungpil Yoon,
• Xiaoju Wang,
• Sompong Vongpunsawad,
• Gerard Tromp,
• Helena Kuivaniemi

Affiliations

Sungpil Yoon

School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

Xiaoju Wang

Department of Pathology, University of Michigan, Ann Arbor, MI, United States

Sompong Vongpunsawad

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Gerard Tromp

Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Tygerberg, South Africa

Helena Kuivaniemi

Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Stellenbosch University, Tygerberg, South Africa